Ecstasy to treat post-traumatic stress disorder?

18 September 2012 Last updated at 03:06 ET Help

Prof David Nutt explains why the drug ecstasy or MDMA is being studied in clinical research and how it could be useful for treating post-traumatic stress disorder by controlling intrusive, traumatic memories.

Professor Nutt is a psychiatrist and one of the country's leading experts on the effects of drugs on the brain. He was sacked in 2009 as the government's chief drugs adviser after criticising its decision to reclassify cannabis.

Hear the full interview with David Nutt on BBC Radio 4's The Life Scientific.

BBC © 2013 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.